Professor Bruno Morgan

Professor of Cancer Imaging and Radiology

Prof. Bruno Morgan

Level 2 Windsor Building, Radiology Dept. Leicester Royal Infirmary, Leicester LE1 5WW

Tel: +44 (0)116 223 3332


Personal details

  • BA (hons) (1986) Oxford University
  • BM BCh (1989) Oxford University
  • PhD (Medical Imaging) (2006) University of Leicester
  • PGCert Management (2001) De Monfort University
  • MRCP (UK) (1992) Royal College of Physicians
  • FRCR (UK) (1995) Royal College of Radiologists
  • CCT Specialist Register Radiology 1998

University Hospitals of Leicester, Clinical interventional and diagnostic radiology: I manage the use of imaging in research.

University of Leicester: I research and teach relating to oncology and forensic imaging.



I teach medical students, doctors and the pharmaceutical industry imaging applications of cancer and cancer research, including being a faculty member for five years on the ECCO ‘Methods in Clinical Cancer Research’ workshop in Flims, Switzerland.

I also give talks at numerous pharmaceutical company events, to Cancer Research UK, and the European School of Oncology ‘Programme for Oncology Leaders’.

I have also taught on postmortem imaging to coroner's continuation training courses and the Leicester postmortem imaging course.

  • Opportunities and pitfalls of cancer imaging in clinical trials. Nature Reviews Clinical Oncology (2011:8(9); 517-527)
  • Evaluating vascular function for early stage clinical trials using dynamic contrast enhanced MRI (Consensus statement for the use of DCE-MRI in clinical trials). Leach MO, Morgan B, Tofts PS, et al. Eur Radiol. 2012 Jul;22(7):1451-64).
  • Postmortem Computed Tomography (PMCT) Scanning with Angiography (PMCTA): A Description of Three Distinct Methods. Morgan B, Sakamoto N, Shiotani S, Grabherr S  in pp 1-21 Essentials of Autopsy Practice (2014) ed Rutty GN, Springer London
  • Targeted Coronary Post-Mortem Computed Tomography Angiography. Morgan B., Robinson C, Rutty GN. Chapter 8 in Atlas of Postmortem Angiography (in press 2015, Springer) ed. Grabherr S, Grimm J, Heinemann A (Springer)


To view a selection of my publications, please use the link below:


Identification and development of imaging biomarkers for treatment efficacy

  • Imaging applications to monitor drug therapy. This has involved the study of novel drug therapies and more recently natural chemo-preventative agents.
  • I also manage the use of all imaging in cancer research at University Hospital Leicester providing oversight for all scans performed for clinical trials including CT, MRI, Ultrasound and PET-CT.

Forensic imaging

Post mortem imaging, particularly related to CT scanning, with the East Midlands Forensic Pathology team, led by Professor Guy Rutty.

  • Scanned over 600 consented research post-mortem cases in the last five years, all with autopsy correlation
    • 270 of them with targeted coronary angiography
    • 50 with ‘whole-body’ angiography in collaboration with Lausanne (Swz) and several European centres
  • We have published over 25 papers on the subject in the last five years and have
    • helped pioneer the concept of mobile CT in temporary mortuaries for mass fatalities, a process now being adopted around the world
    • advised the home office, department of health and Interpol on post mortem imaging issues

Other research interests

I also provide assistance to imaging aspects of research into body composition analysis studies, cardiovascular and respiratory diseases.

Share this page:


Powerful pre-clinical platform for anti-cancer drug and biomarker discovery

Pre-clinical models that can accurately predict outcomes in the clinic are much sort after in the field of cancer drug discovery and development.  Read about how patient derived explants offer many advantages and are the powerful model of choice. A copy of the review, published in the British Journal of Cancer, is available by clicking this link: PDE Platform


SEND Study Success

Congratulations to Chris Avery, who with collaborating colleagues published findings of the SEND study, a multi-centre randomised trial using two different surgical protocols for mouth cancer treatment.  A nationwide first for this type of trial, using real-world data.  The paper, published in the British Journal of Cancer, is available by clicking this link: SEND Paper


Centre Health and Wellbeing Group
Join up for a walk on the park Friday lunchtime - details here.

More information from Jenny McNair

Contact Details

Leicester Cancer Research Centre
Robert Kilpatrick Clinical Sciences Building
University of Leicester
Leicester Royal Infirmary
Leicester LE2 7LX

T: +44 (0) 116 252 3170

(Please note this email address should not be used for clinical referrals or patient correspondence)

Maps and Directions

Sat Nav users: 


AccessAble logo

The University of Leicester is committed to equal access to our facilities. DisabledGo has a detailed accessibility guide for the Robert Kilpatrick Clinical Sciences Building.